BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
BioLine Rx | F-3: Registration statement for specified transactions by certain foreign private issuers
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data
No Data